Distributors often don’t lack strategy — they lack execution. Drawing from industry research and frontline realities, this ...

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIR™ CRANFORD, N.J., July 15, 2025 ...

Celsius's acquisition of Alani Nu is strategically sound, expanding its market reach and product portfolio, but integration and distribution execution risks remain. International expansion is gaining ...